Treatment of Hematological Malignancy With Novel CAR-T Cells.

Clinical trial NCT04191941 · UNKNOWN

Trial details

NCT number: NCT04191941
Sponsor: Timmune Biotech Inc.
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

B-cell Non Hodgkin Lymphoma B-cell Acute Lymphoblastic Leukemia Multiple Myeloma

Start date: 2019-09-01
Primary completion: 2021-08-31
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.